|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.395 EUR | -3.66% |
|
-3.54% | -14.13% |
| Apr. 05 | GenSight: financial visibility assured until the end of April | CF |
| Mar. 25 | GenSight: share price falls, limited financial visibility | CF |
GenSight Biologics S.A. announced that Thomas Gidoin, Chief Financial Officer since 2015, has resigned, effective January 26, 2024. An interim CFO was appointed until a permanent replacement is recruited.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.13% | 32.96M | |
| -3.45% | 102B | |
| +1.53% | 96.09B | |
| +2.13% | 22.28B | |
| -16.65% | 21.4B | |
| -9.40% | 18.14B | |
| -39.98% | 17.02B | |
| -14.45% | 16.09B | |
| +5.22% | 13.83B | |
| +32.21% | 11.97B |
GENSIGHT BIOLOGICS S.A. 
